{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:51:21Z","timestamp":1791355881840,"version":"4.3.1"},"reference-count":100,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["bprch.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.beha.2016.08.007","type":"journal-article","created":{"date-parts":[[2016,8,12]],"date-time":"2016-08-12T01:53:09Z","timestamp":1470966789000},"page":"40-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["The chronic lymphocytic leukemia microenvironment: Beyond the B-cell receptor"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9107-2186","authenticated-orcid":false,"given":"Michael Y.","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj Kumar","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.beha.2016.08.007_bib1","first-page":"98","article-title":"The distribution of secondary growths in cancer of the breast","volume":"1989","author":"Paget","year":"1889","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.beha.2016.08.007_bib2","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.beha.2016.08.007_bib3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1200\/EdBook_AM.2013.33.e91","article-title":"Cellular composition of the tumor microenvironment","author":"Ansell","year":"2013","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.beha.2016.08.007_bib4","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature15395","article-title":"Mutations driving CLL and their evolution in progression and relapse","volume":"526","author":"Landau","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.beha.2016.08.007_bib5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2141.1989.tb04290.x","article-title":"Spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culture in\u00a0vitro","volume":"71","author":"Collins","year":"1989","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2016.08.007_bib6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1053\/j.semdp.2011.02.014","article-title":"Chronic lymphocytic leukemia: the pathologist's view of lymph node microenvironment","volume":"28","author":"Ponzoni","year":"2011","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.beha.2016.08.007_bib7","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1172\/JCI23409","article-title":"In\u00a0vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells","volume":"115","author":"Messmer","year":"2005","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.beha.2016.08.007_bib8","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1182\/blood-2010-05-284984","article-title":"The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia","volume":"117","author":"Herishanu","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.08.007_bib9","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/PPO.0b013e31826c5810","article-title":"Inhibitors of B-cell receptor signaling for patients with B-cell malignancies","volume":"18","author":"Choi","year":"2012","journal-title":"Cancer J"},{"key":"10.1016\/j.beha.2016.08.007_bib10","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.3109\/10428194.2012.695781","article-title":"Targeting the B cell receptor pathway in chronic lymphocytic leukemia","volume":"53","author":"Davids","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.beha.2016.08.007_bib11","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1182\/blood.V96.8.2655","article-title":"Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1","volume":"96","author":"Burger","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.08.007_bib12","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bcmd.2012.12.003","article-title":"Circulating microenvironment of CLL: are nurse-like cells related to tumor-associated macrophages?","volume":"50","author":"Filip","year":"2013","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.beha.2016.08.007_bib13","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1182\/blood-2013-10-529610","article-title":"Extracellular HMGB1 promotes differentiation of nurse-like cells in chronic lymphocytic leukemia","volume":"123","author":"Jia","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.08.007_bib14","doi-asserted-by":"crossref","first-page":"6071","DOI":"10.4049\/jimmunol.1102066","article-title":"Stromal endothelial cells establish a bidirectional crosstalk with chronic lymphocytic leukemia cells through the TNF-related factors BAFF, APRIL, and CD40L","volume":"188","author":"Cols","year":"2012","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.beha.2016.08.007_bib15","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1182\/blood-2010-05-284505","article-title":"Soluble CD14 is a novel monocyte-derived survival factor for chronic lymphocytic leukemia cells, which is induced by CLL cells in\u00a0vitro and present at abnormally high levels in\u00a0vivo","volume":"116","author":"Seiffert","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.08.007_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10238-013-0268-z","article-title":"Guilty bystanders: nurse-like cells as a model of microenvironmental support for leukemic lymphocytes","volume":"15","author":"Filip","year":"2015","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.beha.2016.08.007_bib17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2119\/molmed.2011.00164","article-title":"Sorafenib-induced apoptosis of chronic lymphocytic leukemia cells is associated with downregulation of RAF and myeloid cell leukemia sequence 1 (Mcl-1)","volume":"18","author":"Fecteau","year":"2012","journal-title":"Mol Med"},{"key":"10.1016\/j.beha.2016.08.007_bib18","doi-asserted-by":"crossref","first-page":"5622","DOI":"10.1158\/1078-0432.CCR-06-1204","article-title":"Magnitude of stromal hemangiogenesis correlates with histologic subtype of non-Hodgkin's lymphoma","volume":"12","author":"Ruan","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.beha.2016.08.007_bib19","doi-asserted-by":"crossref","first-page":"7632","DOI":"10.18632\/oncotarget.2939","article-title":"Co-culture of primary CLL cells with bone marrow mesenchymal cells, CD40 ligand and CpG ODN promotes proliferation of chemoresistant CLL cells phenotypically comparable to those proliferating in\u00a0vivo","volume":"6","author":"Purroy","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.beha.2016.08.007_bib20","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1182\/blood-2014-10-607036","article-title":"Stromal cell-mediated glycolytic switch in CLL cells involves Notch-c-Myc signaling","volume":"125","author":"Jitschin","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.08.007_bib21","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1073\/pnas.0712148105","article-title":"Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a","volume":"105","author":"Fukuda","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beha.2016.08.007_bib22","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1182\/blood.V94.11.3658","article-title":"Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells","volume":"94","author":"Burger","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.08.007_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2012.12.003","article-title":"Protein kinase c-beta-dependent activation of NF-kappaB in stromal cells is indispensable for the survival of chronic lymphocytic leukemia B cells in\u00a0vivo","volume":"23","author":"Lutzny","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.beha.2016.08.007_bib24","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1182\/blood-2010-02-269894","article-title":"Platelet-derived growth factor (PDGF)-PDGF receptor interaction activates bone marrow-derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switch","volume":"116","author":"Ding","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.08.007_bib25","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1182\/blood-2014-12-618025","article-title":"Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts","volume":"126","author":"Paggetti","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.08.007_bib26","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1182\/blood-2010-12-324210","article-title":"A\u00a0novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease","volume":"117","author":"Bagnara","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.08.007_bib27","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1182\/blood-2012-09-457531","article-title":"T\u00a0cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production","volume":"121","author":"Riches","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.08.007_bib28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1182\/blood-2015-01-622936","article-title":"PD-L1 checkpoint blockade prevents immune dysfunction and leukemia development in a mouse model of chronic lymphocytic leukemia","volume":"126","author":"McClanahan","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.08.007_bib29","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1182\/blood-2005-02-0642","article-title":"Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine","volume":"106","author":"Beyer","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.08.007_bib30","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.leukres.2008.08.021","article-title":"Disruption of T cell suppression in chronic lymphocytic leukemia by CD200 blockade","volume":"33","author":"Pallasch","year":"2009","journal-title":"Leuk Res"},{"key":"10.1016\/j.beha.2016.08.007_bib31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/ajh.2830240207","article-title":"Restoration of impaired natural killer cell activity of B-chronic lymphocytic leukemia patients by recombinant interleukin-2","volume":"24","author":"Kay","year":"1987","journal-title":"Am J Hematol"},{"key":"10.1016\/j.beha.2016.08.007_bib32","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/leu.2008.15","article-title":"NK resistance of tumor cells from multiple myeloma and chronic lymphocytic leukemia patients: implication of HLA-G","volume":"22","author":"Maki","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2016.08.007_bib33","doi-asserted-by":"crossref","first-page":"e108326","DOI":"10.1371\/journal.pone.0108326","article-title":"Expansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia. Correlation with progressive disease","volume":"9","author":"Huergo-Zapico","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.beha.2016.08.007_bib34","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1182\/blood-2013-12-546416","article-title":"CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs","volume":"124","author":"Jitschin","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.08.007_bib35","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.canlet.2015.01.021","article-title":"The STAT3 inhibitor WP1066 reverses the resistance of chronic lymphocytic leukemia cells to histone deacetylase inhibitors induced by interleukin-6","volume":"359","author":"Lu","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.beha.2016.08.007_bib36","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1073\/pnas.1221841110","article-title":"Targeting chronic lymphocytic leukemia cells with a humanized monoclonal antibody specific for CD44","volume":"110","author":"Zhang","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beha.2016.08.007_bib37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3389\/fimmu.2015.00135","article-title":"Modulation of CD44 activity by A6-peptide","volume":"6","author":"Finlayson","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.beha.2016.08.007_bib38","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.leukres.2015.04.016","article-title":"Differential expression and function of CD27 in chronic lymphocytic leukemia cells expressing ZAP-70","volume":"39","author":"Lafarge","year":"2015","journal-title":"Leuk Res"},{"key":"10.1016\/j.beha.2016.08.007_bib39","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1182\/blood-2009-06-225326","article-title":"The microenvironment in mature B-cell malignancies: a target for new treatment strategies","volume":"114","author":"Burger","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.08.007_bib40","doi-asserted-by":"crossref","DOI":"10.13055\/ojhmt_3_S1_03.120221","article-title":"Cell trafficking in chronic lymphocytic leukemia","volume":"3","author":"Davids","year":"2012","journal-title":"Open J Hematol"},{"key":"10.1016\/j.beha.2016.08.007_bib41","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.2119\/molmed.2011.00360","article-title":"Intraclonal complexity in chronic lymphocytic leukemia: fractions enriched in recently born\/divided and older\/quiescent cells","volume":"17","author":"Calissano","year":"2011","journal-title":"Mol Med"},{"key":"10.1016\/j.beha.2016.08.007_bib42","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1084\/jem.177.6.1821","article-title":"Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes","volume":"177","author":"Schall","year":"1993","journal-title":"J\u00a0Exp Med"},{"issue":"11","key":"10.1016\/j.beha.2016.08.007_bib43","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1182\/blood-2015-02-626291","article-title":"L-selectin controls trafficking of chronic lymphocytic leukemia cells in lymph node high endothelial venules in\u00a0vivo","volume":"126","author":"Lafouresse","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.08.007_bib44","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/ni0404-351","article-title":"Crawling and INTEGRating apical cues","volume":"5","author":"Alon","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.beha.2016.08.007_bib45","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/smim.2001.0346","article-title":"From rolling to arrest on blood vessels: leukocyte tap dancing on endothelial integrin ligands and chemokines at sub-second contacts","volume":"14","author":"Alon","year":"2002","journal-title":"Semin Immunol"},{"key":"10.1016\/j.beha.2016.08.007_bib46","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1073\/pnas.051626198","article-title":"BLNK mediates Syk-dependent Btk activation","volume":"98","author":"Baba","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beha.2016.08.007_bib47","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","article-title":"AKT\/PKB signaling: navigating downstream","volume":"129","author":"Manning","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.beha.2016.08.007_bib48","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1073\/pnas.012605099","article-title":"Phosphoinositide 3-kinase and Bruton's tyrosine kinase regulate overlapping sets of genes in B lymphocytes","volume":"99","author":"Fruman","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beha.2016.08.007_bib49","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1182\/blood-2014-03-559690","article-title":"MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia","volume":"124","author":"Cui","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.08.007_bib50","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1038\/leu.2015.50","article-title":"Neutralization of (NK-cell-derived) B-cell activating factor by Belimumab restores sensitivity of chronic lymphoid leukemia cells to direct and Rituximab-induced NK lysis","volume":"29","author":"Wild","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2016.08.007_bib51","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/ijc.24832","article-title":"Toll-like receptors on B-CLL cells: expression and functional consequences of their stimulation","volume":"126","author":"Rozkova","year":"2010","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.beha.2016.08.007_bib52","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1182\/blood-2014-12-618678","article-title":"Microenvironmental interleukin-6 suppresses toll-like receptor signaling in human leukemia cells through miR-17\/19A","volume":"126","author":"Li","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.08.007_bib53","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.cellsig.2012.03.008","article-title":"Interactions between bone marrow stromal microenvironment and B-chronic lymphocytic leukemia cells: any role for Notch, Wnt and Hh signaling pathways?","volume":"24","author":"Seke Etet","year":"2012","journal-title":"Cell Signal"},{"key":"10.1016\/j.beha.2016.08.007_bib54","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.neo.2014.10.002","article-title":"Regulation of Mcl-1 expression in context to bone marrow stromal microenvironment in chronic lymphocytic leukemia","volume":"16","author":"Balakrishnan","year":"2014","journal-title":"Neoplasia"},{"key":"10.1016\/j.beha.2016.08.007_bib55","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3109\/10428194.2013.819573","article-title":"Impact of bone marrow stromal cells on Bcl-2 family members in chronic lymphocytic leukemia","volume":"55","author":"Patel","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.beha.2016.08.007_bib56","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1182\/blood-2012-02-414060","article-title":"Decreased mitochondrial apoptotic priming underlies stroma-mediated treatment resistance in chronic lymphocytic leukemia","volume":"120","author":"Davids","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.08.007_bib57","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.3109\/10428194.2013.796051","article-title":"Overcoming stroma-mediated treatment resistance in chronic lymphocytic leukemia through BCL-2 inhibition","volume":"54","author":"Davids","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.beha.2016.08.007_bib58","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1365-2141.2007.06717.x","article-title":"CD154 induces a switch in pro-survival Bcl-2 family members in chronic lymphocytic leukaemia","volume":"138","author":"Willimott","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2016.08.007_bib59","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3324\/haematol.2014.122069","article-title":"Targeting the spliceosome in chronic lymphocytic leukemia with the macrolides FD-895 and pladienolide-B","volume":"100","author":"Kashyap","year":"2015","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.beha.2016.08.007_bib60","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/leu.2015.286","article-title":"The SF3B1 inhibitor spliceostatin A (SSA) elicits apoptosis in Chronic Lymphocytic Leukemia cells through downregulation of Mcl-1","volume":"30","author":"Larrayoz","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2016.08.007_bib61","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1215637","article-title":"Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia","volume":"369","author":"Byrd","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beha.2016.08.007_bib62","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2141.2010.08316.x","article-title":"The microenvironment differentially impairs passive and active immunotherapy in chronic lymphocytic leukaemia - CXCR4 antagonists as potential adjuvants for monoclonal antibodies","volume":"151","author":"Buchner","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2016.08.007_bib63","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1182\/blood-2013-03-493924","article-title":"The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization","volume":"123","author":"Hoellenriegel","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.08.007_bib64","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1182\/blood.V126.23.4162.4162","article-title":"Targeting the CXCR4 pathway using an anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia","volume":"126","author":"Kashyap","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.08.007_bib65","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.18632\/oncotarget.6465","article-title":"Ulocuplumab (BMS-936564\/MDX1338): a fully human anti-CXCR4 antibody induces cell death in chronic lymphocytic leukemia mediated through a reactive oxygen species-dependent pathway","volume":"7","author":"Kashyap","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.beha.2016.08.007_bib66","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1182\/blood.V122.21.4190.4190","article-title":"BMS-936564 (Anti-CXCR4 antibody) induces specific leukemia cell mobilization and objective clinical responses in CLL patients treated under a phase I clinical trial","volume":"122","author":"Kashyap","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.08.007_bib67","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1182\/blood-2010-04-282400","article-title":"Chronic lymphocytic leukemia cells receive RAF-dependent survival signals in response to CXCL12 that are sensitive to inhibition by sorafenib","volume":"117","author":"Messmer","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.08.007_bib68","first-page":"1","article-title":"The MEK1\/2 inhibitor, MEKi-1, induces cell death in Chronic Lymphocytic Leukemia cells under conditions that mimic the tumor microenvironment and is synergistic with fludarabine","author":"Crassini","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.beha.2016.08.007_bib69","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1200\/JCO.2010.29.8133","article-title":"Single-agent lenalidomide in the treatment of previously untreated chronic lymphocytic leukemia","volume":"29","author":"Chen","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.beha.2016.08.007_bib70","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1200\/JCO.2013.51.5890","article-title":"Lenalidomide and rituximab for the initial treatment of patients with chronic lymphocytic leukemia: a multicenter clinical-translational study from the chronic lymphocytic leukemia research consortium","volume":"32","author":"James","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.beha.2016.08.007_bib71","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S1470-2045(06)70723-9","article-title":"Immunomodulating drugs for chronic lymphocytic leukaemia","volume":"7","author":"Chanan-Khan","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.beha.2016.08.007_bib72","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1182\/blood-2014-03-559591","article-title":"Lenalidomide inhibits the proliferation of CLL cells via a cereblon\/p21(WAF1\/Cip1)-dependent mechanism independent of functional p53","volume":"124","author":"Fecteau","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.08.007_bib73","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1182\/blood-2012-08-447664","article-title":"Lenalidomide reduces survival of chronic lymphocytic leukemia cells in primary cocultures by altering the myeloid microenvironment","volume":"121","author":"Schulz","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.08.007_bib74","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1182\/blood-2012-08-448332","article-title":"Chronic lymphocytic leukemia cells induce defective LFA-1-directed T-cell motility by altering Rho GTPase signaling that is reversible with lenalidomide","volume":"121","author":"Ramsay","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.08.007_bib75","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1182\/blood-2012-12-470005","article-title":"Long-term repair of T-cell synapse activity in a phase II trial of chemoimmunotherapy followed by lenalidomide consolidation in previously untreated chronic lymphocytic leukemia (CLL)","volume":"121","author":"Shanafelt","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.08.007_bib76","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/MOH.0000000000000158","article-title":"Targeting immune checkpoints in lymphoma","volume":"22","author":"Ansell","year":"2015","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.beha.2016.08.007_bib77","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1182\/blood-2006-06-027755","article-title":"BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway","volume":"109","author":"Endo","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.08.007_bib78","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1182\/blood-2004-03-0889","article-title":"Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha","volume":"106","author":"Nishio","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.08.007_bib79","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/bjh.12645","article-title":"B\u00a0cell activation through CD40 and IL4R ligation modulates the response of chronic lymphocytic leukaemia cells to BAFF and APRIL","volume":"164","author":"Ferrer","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2016.08.007_bib80","first-page":"478753","article-title":"TACI expression and signaling in chronic lymphocytic leukemia","volume":"2015","author":"Mamara","year":"2015","journal-title":"J\u00a0Immunol Res"},{"key":"10.1016\/j.beha.2016.08.007_bib81","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1182\/blood-2007-06-094029","article-title":"CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential","volume":"110","author":"Deaglio","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.08.007_bib82","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4065\/79.3.318","article-title":"Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia\/small lymphocytic lymphoma","volume":"79","author":"Ghobrial","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.beha.2016.08.007_bib83","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1182\/blood-2007-05-089409","article-title":"Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia","volume":"110","author":"Burkle","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.08.007_bib84","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1158\/2159-8290.CD-14-0096","article-title":"Access to follicular dendritic cells is a pivotal step in murine chronic lymphocytic leukemia B-cell activation and proliferation","volume":"4","author":"Heinig","year":"2014","journal-title":"Cancer Discov"},{"key":"10.1016\/j.beha.2016.08.007_bib85","doi-asserted-by":"crossref","first-page":"e98818","DOI":"10.1371\/journal.pone.0098818","article-title":"Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through ETA receptor","volume":"9","author":"Maffei","year":"2014","journal-title":"PLoS One"},{"issue":"Suppl","key":"10.1016\/j.beha.2016.08.007_bib86","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.1016\/j.clml.2015.02.010","article-title":"Pre-clinical specificity and safety of UC-961, a first-in-class monoclonal antibody targeting ROR1","volume":"15","author":"Choi","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.beha.2016.08.007_bib87","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000430980","article-title":"Expression of programmed death 1 ligand in different compartments of chronic lymphocytic leukemia","volume":"134","author":"Grzywnowicz","year":"2015","journal-title":"Acta Haematol"},{"key":"10.1016\/j.beha.2016.08.007_bib88","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1182\/blood-2008-05-158618","article-title":"Mouse models of non-Hodgkin lymphoma reveal Syk as an important therapeutic target","volume":"113","author":"Young","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.08.007_bib89","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/378298a0","article-title":"Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk","volume":"378","author":"Turner","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.beha.2016.08.007_bib90","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/1521-4141(200205)32:5<1403::AID-IMMU1403>3.0.CO;2-Y","article-title":"Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22","volume":"32","author":"Ghia","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.beha.2016.08.007_bib91","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/ni735","article-title":"B\u00a0cells and professional APCs recruit regulatory T cells via CCL4","volume":"2","author":"Bystry","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.beha.2016.08.007_bib92","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1182\/blood-2008-07-170415","article-title":"High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation","volume":"113","author":"Burger","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.08.007_bib93","first-page":"453634","article-title":"Gene expression and serum cytokine profiling of low stage CLL identify WNT\/PCP, Flt-3L\/Flt-3 and CXCL9\/CXCR3 as regulators of cell proliferation, survival and migration","volume":"2009","author":"Mahadevan","year":"2009","journal-title":"Hum Genom Proteom"},{"key":"10.1016\/j.beha.2016.08.007_bib94","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1124\/jpet.113.203489","article-title":"Inhibition of Btk with CC-292 provides early pharmacodynamic assessment of activity in mice and humans","volume":"346","author":"Evans","year":"2013","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.beha.2016.08.007_bib95","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1182\/blood-2011-05-352492","article-title":"The phosphoinositide 3\u2032-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia","volume":"118","author":"Hoellenriegel","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.08.007_bib96","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1002\/ijc.29579","article-title":"Efficacy of phosphatidylinositol-3 kinase inhibitors with diverse isoform selectivity profiles for inhibiting the survival of chronic lymphocytic leukemia cells","volume":"137","author":"Gockeritz","year":"2015","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.beha.2016.08.007_bib97","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/leu.2015.241","article-title":"The pan phosphoinositide 3-kinase\/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib\/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells","volume":"30","author":"Thijssen","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2016.08.007_bib98","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1182\/blood-2009-08-236471","article-title":"Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia","volume":"115","author":"Friedberg","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.beha.2016.08.007_bib99","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/leu.2012.24","article-title":"Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migration","volume":"26","author":"Hoellenriegel","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2016.08.007_bib100","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.leukres.2013.10.004","article-title":"Dasatinib in combination with fludarabine in patients with refractory chronic lymphocytic leukemia: a multicenter phase 2 study","volume":"38","author":"Kater","year":"2014","journal-title":"Leuk Res"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692616300093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692616300093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T03:31:31Z","timestamp":1601004691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692616300093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S1521692616300093"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2016.08.007","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The chronic lymphocytic leukemia microenvironment: Beyond the B-cell receptor","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Haematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beha.2016.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}